Update on EGFR-mutated non-small cell lung cancer

Hämta fulltext

CompEx asthma a novel composite exacerbation endpoint /

Hämta fulltext
Series

Immunotherapy insights from advanced disease /

Hämta fulltext
Series

Ovarian cancer progression of tumors /

Hämta fulltext
Series

The evolving role of novel and next generation therapies in the management of multiple myeloma part 1 of 2, introduction and current therapies /

Hämta fulltext

The evolving role of novel and next generation therapies in the management of multiple myeloma part 2 of 2, relapse refractory multiple myeloma /

Hämta fulltext

Clinical trial designs for rare diseases part 1 of 2, trial designs /

Hämta fulltext

Clinical trial designs for rare diseases part 2 of 2, trial protocols /

Hämta fulltext

Management of sickle cell disease what to do when there is no evidence base /

Hämta fulltext

Research & development of new pharmaceuticals for treatment of endometriosis

Hämta fulltext

Lysosomal storage diseases

Hämta fulltext
Series

Latest developments & future directions in the management of chronic pain

Hämta fulltext
Series

Systemic lupus erythematosus novel aspects of pathogenesis and treatment, part 2 of 2 /

Hämta fulltext
Series

GPCRs and pain

Hämta fulltext
Series

Novel approaches to treating symptoms and slowing the progress of neurodegenerative diseases

Hämta fulltext
Series

Multiple myeloma an overview /

Hämta fulltext

Prolactin has a pathogenic role in systemic lupus erythematosus

Hämta fulltext
Series

Advances in the treatment of NASH

Hämta fulltext

Adapting proteostasis to ameliorate aggregation-associated amyloid diseases

Hämta fulltext
Series

Pharmacotherapy for obesity part 1, the need for pharmacotherapy in weight management /

Hämta fulltext